Why ESPR? Esperion Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
ESPR
$3.11+1.11 (+55.50%)
Market ClosedLast close May 1
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.